We are live on ! Find out more
NAUT icon

Nautilus Biotechnolgy
NAUT

88 hedge funds and large institutions have $107M invested in Nautilus Biotechnolgy in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 17

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

6% more funds holding

Funds holding: 83 → 88 (+5)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.32% less ownership

Funds ownership: 51.18% → 50.87% (-0.32%)

41% less capital invested

Capital invested by funds: $183M → $107M (-$75.6M)

Holders
88
Holders Change
+5
Holders Change %
+6.02%
% of All Funds
1.16%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
16
Increased
26
Reduced
17
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$337K
2
JP Morgan Chase
JP Morgan Chase
New York
+$264K
3
WC
Wexford Capital
Florida
+$232K
4
Renaissance Technologies
Renaissance Technologies
New York
+$228K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$187K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.19M
2
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$576K
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$449K
4
CC
Clearline Capital
New York
-$411K
5
ST
Sentinel Trust
Texas
-$144K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$245K +$264K +110,334 +310%
Barclays
27
Barclays
United Kingdom
$210K +$45.5K +19,030 +18%
Charles Schwab
28
Charles Schwab
California
$194K -$53.2K -22,256 -16%
Jane Street
29
Jane Street
New York
$182K +$169K +70,863 +188%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$179K – – –
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$123K +$5.97K +2,497 +4%
HSBC Holdings
32
HSBC Holdings
United Kingdom
$92.2K +$85.3K +35,650 +183%
Bank of America
33
Bank of America
North Carolina
$83K +$32K +13,363 +37%
UBS Group
34
UBS Group
Switzerland
$79.3K +$46.5K +19,449 +70%
Corient Private Wealth
35
Corient Private Wealth
Florida
$76.2K – – –
Citigroup
36
Citigroup
New York
$68.2K +$3.8K +1,590 +4%
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$65.5K +$93.3K +39,004 New
Millennium Management
38
Millennium Management
New York
$63.3K +$90.2K +37,704 New
S
39
SignatureFD
Georgia
$62.7K – – –
VCWA
40
Vanguard Capital Wealth Advisors
Colorado
$52.9K -$8.37K -3,500 -10%
BPWM
41
Badgley Phelps Wealth Managers
Washington
$50.4K – – –
Wells Fargo
42
Wells Fargo
California
$48.5K +$6.85K +2,864 +11%
PWM
43
Palumbo Wealth Management
New York
$47.8K +$21.3K +8,888 +45%
Mirae Asset Global ETFs Holdings
44
Mirae Asset Global ETFs Holdings
Hong Kong
$46.8K +$2.91K +1,216 +5%
SG Americas Securities
45
SG Americas Securities
New York
$46K +$23.7K +9,904 +56%
Squarepoint
46
Squarepoint
New York
$44.2K +$63K +26,324 New
CF
47
Corebridge Financial
Texas
$40.7K -$4.37K -1,828 -7%
LSAG
48
Lake Street Advisors Group
New Hampshire
$38.2K – – –
Deutsche Bank
49
Deutsche Bank
Germany
$37.6K – – –
AllianceBernstein
50
AllianceBernstein
Tennessee
$36.1K – – –
1
2
3 4

NAUT Hedge Fund Activity: Q4 2024 in Review

88 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Nautilus Biotechnolgy (NAUT) for Q4 2024, worth a combined $107M — down 41% from $183M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new NAUT positions and 11 closed out — a net gain of 5 holders — while 26 added to existing stakes and 17 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $337K. The largest seller was BlackRock, cutting an estimated $1.19M.

  • 88 institutional investors held Nautilus Biotechnolgy (NAUT) as of Q4 2024, up from 83 in Q3 2024.
  • Funds reported $107M of Nautilus Biotechnolgy stock for Q4 2024, down 41% quarter-over-quarter.
  • 16 funds opened new Nautilus Biotechnolgy positions in Q4 2024 and 11 closed out, a net change of +5 holders.
  • The largest Nautilus Biotechnolgy buyer in Q4 2024 was Citadel Advisors, an estimated $337K added.
  • The largest Nautilus Biotechnolgy seller in Q4 2024 was BlackRock, an estimated $1.19M sold.

Based on aggregated 13F filings for Q4 2024.